The role of Bcl-xL and nuclear factor-κB in the effect of taxol on the viability of dendritic cells

Journal of Veterinary Science

Volumn 10, Issue 2, 2009, Pages 99-103

  Kim, Mi Hyoung ^a   Joo, Hong Gu ^a  

^a Jeju National University   (South Korea)

Author keywords

Apoptosis; Dendritic cell; NF B; Taxol; Viability

Indexed keywords

ANTINEOPLASTIC AGENT; BCL2L1 PROTEIN, MOUSE; INTERLEUKIN 12; PACLITAXEL; PROTEIN BCL X; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CELL SURVIVAL; CONFOCAL MICROSCOPY; CYTOLOGY; DENDRITIC CELL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; MOUSE; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BCL-X PROTEIN; BLOTTING, WESTERN; CELL SURVIVAL; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PACLITAXEL; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949088502     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2009.10.2.99     Document Type: Article

References (23)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998, 392, 245-252.
2. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008, 19, 41-52.
3. Choi GS, Lee MH, Kim SK, Kim CS, Lee HS, Im MW, Kil HY, Seong DH, Lee JR, Kim WC, Lee MG, Song SU. Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (Paclitaxel) for murine fibrosarcoma. Yonsei Med J 2005, 46, 835-842.
4. Chu Q, Vincent M, Logan D, Mackay JA, Evans WK. Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systemic review and practice guideline. Lung Cancer 2005, 50, 355-374.
5. Hou WS, Van Parijs L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 2004, 5, 583-589.
6. Joo HG. Altered maturation of dendritic cells by taxol, an anticancer drug. J Vet Sci 2003, 4, 229-234.
7. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a β-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001, 69, 555-564.
8. Kim HJ, Kim MH, Byon YY, Park JW, Jee Y, Joo HG. Radioprotective effects of an acidic polysaccharide of Panax ginseng on bone marrow cells. J Vet Sci 2007, 8, 39-44.
9. Kim MH, Joo HG. Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells. Immunol Lett 2008, 115, 138-143.
10. Kim YM, Paik SG. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells. Biochem Biophys Res Commun 2005, 326, 410-416.
11. Kriehuber E, Bauer W, Charbonnier AS, Winter D, Amatschek S, Tamandl D, Schweifer N, Stingl G, Maurer D. Balance between NF-κB and JNK/AP-1 activity controls dendritic cell life and death. Blood 2005, 106, 175-183.
12. Kubo M, Morisaki T, Matsumoto K, Tasaki A, Yamanaka N, Nakashima H, Kuroki H, Nakamura K, Nakamura M, Katano M. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production. Cancer Immunol Immunother 2005, 54, 468-476.
13. Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res 2005, 11, 5515-5525.
14. Mullins DW, Burger CJ, Elgert KD. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 1999, 162, 6811-6818.
15. Nopora A, Brocker T. Bcl-2 controls dendritic cell longevity in vivo. J Immunol 2002, 169, 3006-3014.
16. Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003, 4, 410-415.
17. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-(B subunits. Immunity 2002, 16, 257-270.
18. Pirtskhalaishvili G, Shurin GV, Gambotto A, Esche C, Wahl M, Yurkovetsky ZR, Robbins PD, Shurin MR. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J Immunol 2000, 165, 1956-1964.
19. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. pp. 696-698, Churchill Livingston, Kidlington, 2004.
20. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998, 188, 2175-2180.
21. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990, 82, 1247-1259.
22. Wiseman LR, Spencer CM. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers. Drugs Aging 1998, 12, 305-334.
23. Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR, Shurin GV. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clin Cancer Res 2007, 13, 5455-5462.